Wearable Injectors Market Size to Reach USD 15.66 Billion by 2028 | Increasing Demand for More Innovative Devices and Solutions to Improve Quality Of Life Of Patients are Factors Driving Industry Growth, says Emergen Research

Key players in the wearable injectors market include Medtronic, Amgen, Ypsomed, Insulet Corporation, West Pharmaceutical Services, Becton, Dickinson And Company, Enable Injections, United Therapeutics Corporation, F. Hoffmann-La Roche AG, and Johnson & Johnson.


Vancouver, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global wearable injectors market size is projected to reach USD 15.66 Billion by 2028 at a CAGR of 11.2% over the forecast period, according to latest analysis by Emergen Research. This steady growth can be attributed to increasing challenges in delivering large doses or viscous drugs and increasing adoption of electronic wearable injectors due to convenience and reliability of these devices. Electronic wearable injectors improve the adherence of patients with the potential to improve their quality of life and reduce healthcare expenses. Increasing investment by major players in the market for development of more advanced health-related therapies and treatments is projected to open up new growth opportunities in the market. Availability of favorable reimbursement policies in some countries is further boosting adoption of wearables injectors among patients suffering from chronic diseases and disorders.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/543

Some Key Highlights in the Report

  • In February 2020, Abbott entered into a partnership with Insulet Corporation. The association was created to integrate the leading glucose-sensing technology of Abbott with the next-generation tubeless system of Insulet named the Omnipod Horizon Automated Insulin Delivery (AID) System. This is expected to offer personalized automated insulin delivery to diabetics.   
  • Motor-driven segment revenue is expected to expand at a rapid CAGR during the forecast period. The convenience offered by motor-driven wearable injectors makes self-injection safe, easy to use, comfortable, and less painful for patients, which is driving demand for this type of product currently.
  • The on-body wearable injectors segment accounted for largest revenue share in 2020. On-body wearable injectors are designed to enable patients to deliver large volumes of small molecule and biologic therapeutics at home, which is a key factor driving demand for this type of wearable injector.
  • The diabetes segment revenue is projected to increase rapidly during the forecast period, driven by an increasing global diabetic population and rising demand for wearable injectors in order to track and manage therapy and avoid over-dose. 
  • The home care setting segment accounted for largest revenue share in the wearable injectors market in 2020, driven by rising need to reduce healthcare costs and increasing preference for more convenient administration of infusion drug in the home environment.
  • North America market revenue is expected to expand at a steadily inclining CAGR during the forecast period. Increasing prevalence of cardiovascular diseases and diabetes among the aging population in countries in the region is boosting demand for wearable injectors, and thus supporting growth of the North America wearable injectors market to a significant extent.

Check Our Prices@ https://www.emergenresearch.com/select-license/543
Emergen Research has segmented the global wearable injectors market on the basis of technology, type, application, end-use, and region:

  • Technology Outlook (Revenue, USD Billion; 2021–2028)
    • Motor-driven
    • Expanding Battery
    • Spring-based
    • Rotary Pump
    • Others
  • Type Outlook (Revenue, USD Billion; 2021–2028)
    • Off-body
    • On-body             
  • Application Outlook (Revenue, USD Billion; 2021–2028)
    • Cardiovascular Disease
    • Diabetes
    • Immuno-Oncology
    • Infectious Diseases
    • Others        
  • End-use Outlook (Revenue, USD Billion; 2021–2028)
    • Clinics
    • Hospitals
    • Home Care Setting
    • Others  

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   https://www.emergenresearch.com/industry-report/wearable-injectors-market

  • Regional Outlook (Revenue, USD Billion; 2021–2028)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. BENELUX
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release: https://www.emergenresearch.com/press-release/global-wearable-injectors-market